Advertisement
Screener

Cingulate Inc. (CING) ROA

Cingulate Inc. (CING) ROA

  • 2026-06-30: ROA -87.09%.
  • 2026-03-31: ROA -90.43%.
  • 2025-12-31: ROA -148.94%.
  • 2025-09-30: ROA -213.03%.

Complete source-backed roa history.

Available history
2020-12-31 to 2026-06-30
Data captured

Historical ROA

DateROA
2026-06-30-87.09%
2026-03-31-90.43%
2025-12-31-148.94%
2025-09-30-213.03%
2025-06-30-142.50%
2025-03-31-139.86%
2024-12-31-111.40%
2024-09-30-127.12%
2024-06-30-372.87%
2024-03-31-409.55%
2023-12-31-674.08%
2023-09-30-361.23%
2023-06-30-368.31%
2023-03-31-232.83%
2022-12-31-154.99%
2022-09-30-102.26%
2022-06-30-195.51%
2022-03-31-132.26%
2021-12-31-90.49%

Annual ROA

DateROA
2025-12-31-148.94%
2024-12-31-111.40%
2023-12-31-674.08%
2022-12-31-154.99%
2021-12-31-90.49%
2020-12-31-124.12%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Spero Therapeutics, Inc. (SPRO)United States$0.073B17.41
Aldeyra Therapeutics, Inc. (ALDX)United States$0.074B-5.57
Lunai Bioworks Inc. (LNAI)United States$0.072B-0.11
PMV Pharmaceuticals, Inc. (PMVP)United States$0.071B-0.95
TENAX THERAPEUTICS, INC. (TENX)United States$0.071B-7.17
PLIANT THERAPEUTICS, INC. (PLRX)United States$0.071B-0.76
OS Therapies Inc (OSTX)United States$0.076B-2.17
Yarrow Bioscience, Inc. (YARW)United States$0.070B
Verrica Pharmaceuticals Inc. (VRCA)United States$0.076B-3.39
iBio, Inc. (IBIO)United States$0.077B-2.94